| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
4e-05 |